lobbying_activities: 3148485
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3148485 | c4aa1ecd-b3da-4471-aa60-64dad20aa06e | Q1 | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC | 17966 | EMERGENT BIOSOLUTIONS | 2024 | first_quarter | DIS | Further Consolidated Appropriations Act, 2024 - Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; Draft - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2024-04-17T12:33:47-04:00 |